AngioDynamics ANGO 深 沪
等待开盘 10-16 09:30:00 美东时间
11.58
+0.530
+4.80%
华盛通- 最 高11.625
- 今 开11.05
- 成交量 113.69万股
- 最 低 11.05
- 昨 收 11.05
- 总市值 48.70万
- 52周最高 16.29
- 市盈率 静 --
- 换手率 2703.50%
- 52周最低 9.39
- 委 比 -89.10%
- 总股本 4.21万
- 历史最高 32.00
- 量 比 0.62
- 振 幅 5.20%
- 历史最低 5.26
- 每 手 1
- 风险率 1.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18
HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $19 to $18.
10-14 01:09
电话会总结 ｜ AngioDynamics(ANGO)2027财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # AngioDynamics（ANGO）2027财年第一季度业绩回顾摘要 ## 1. 财务业绩：**整体营收表现** - 净销售额（Net Sales）：8,090万美元，同比增长6.9%，主要受医疗科技（MedTech）板块带动。 **分板块营收** - MedTech板块营收：3,990万美元，同比增长13.2%，占公司总营收的49%。 - MedDevice（医疗器械）板块营收：4,100万美元，同比增长1.4%。 **主要产品线营收** - Auryon：1,890万美元，同比增长14.7%（连续21个季度实现双位数增长）。 - 机械血栓切
10-09 12:16
AngioDynamics Stock Is Falling Thursday: What's Going On?
AngioDynamics Inc. (NASDAQ:ANGO) stock plunged more than 21% Thursday despite reporting better-than-expected first-quarter financial results. Trading activity was elevated, with approximately 1.94 million shares changing hands, nearly 3.8 times the 100-day average volume of 510,494 shares. The compa...
10-09 01:44
医疗科技业务增长领跑推动AngioDynamics第一季度营收增长6.9%；重申2027财年展望
AngioDynamics公布2027财年第一季度营收增长6.9%，主要由医疗科技业务板块推动，并重申了其全年销售额和盈利能力预期。
10-09 00:01
AngioDynamics Delivers Q1 2027 Growth, Confirms Outlook
AngioDynamics ( ($ANGO) ) has issued an update. For the fiscal first quarter of...
10-08 19:44
Earnings Scheduled For October 8, 2026
Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss at $0.15 per share on revenue of $266.42 million. • Helen Of Troy (NASDAQ:HELE) is projected to report quarterly earnings at $0.46 per share on revenue of $442.15 million. • Ryde Group (AMEX:RYDE) is...
10-08 19:11
AngioDynamics CEO Jim Clemmer to retire
AngioDynamics (ANGO) said Eric Honroth will become president and chief executive officer and join the company’s board of directors, effective Nov. 2, 2026. Honroth will succeed Jim Clemmer, who will s...
10-08 18:16
AngioDynamics Appoints Eric Honroth As President And CEO, Effective November 2
Mr. Honroth will succeed Jim Clemmer, who will depart the Board on November 2, 2026, and will remain in a consulting capacity to ensure a smooth transition. The appointment follows a Board-led search prioritizing a leader with medical technology experience, a demonstrated track record of commercial ...
10-08 18:14
AngioDynamics Affirms FY2027 Adj EPS Guidance of $(0.29)-$(0.24) vs $(0.27) Est; Affirms FY2027 Sales Guidance of $336.000M-$341.000M vs $337.400M Est
AngioDynamics (NASDAQ:ANGO) affirms FY2027 Adj EPS guidance from $(0.29)-$(0.24) to $(0.29)-$(0.24) vs $(0.27) analyst estimate. Affirms FY2027 sales outlook from $336.000 million-$341.000 million to $336.000 million-$341.000 million vs $337.400 million estimate.
10-08 18:03
